ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025
Smoking Cessation in Black Adults: Differences by Sex and Age.
Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionFemales have poorer smoking cessation outcomes than males, especially with nicotine replacement therapy (NRT)-aided attempts, perhaps due to ovarian hormones. In addition, Black adults experience higher rates of tobacco-related mortality and also experience important ovarian hormone differences. This is the first study to examine sex, age, and menopause differences in NRT-aided smoking cessation outcomes in an all-Black sample. AIMS AND
methodsA secondary data analysis was conducted on non-Hispanic Black adults aged 18 + who smoked 5-30 cigarettes/day for at least 6 months. Participants were categorized by sex assigned at birth (female versus male) and age (< 45 versus ≥ 45 years) with females in the ≥ 45 age group restricted to those who were postmenopausal (defined as 1 year post menses per self-report). Smoking status 2 weeks post-quit date was assessed by cessation attempts, expired carbon monoxide-verified abstinence, and reduction in daily cigarettes. Statistical analyses utilized Mann-Whitney rank-sum tests, chi-square tests, and regression models controlling for baseline cigarettes/day.
resultsParticipants (n = 340; 55.9% female) were, on average 53.4 (standard deviation: ± 11.6) years old. At baseline, males smoked significantly more cigarettes/day than females (13.9 ± 7.7 versus 11.9 ± 6.3, respectively; p-value = .031). Among those < 45 years of age, males (n = 30) had a greater reduction in cigarettes/day 2 weeks post cessation than females (n = 52; 11.3 ± 6.1 versus 7.9 ± 5.3, respectively; p-value = .008), but this difference became null after adjusting for baseline cigarettes/day (p-value = .989). No other significant differences were identified.
conclusionsAfter adjusting for baseline differences in smoking rate, no significant sex differences in smoking cessation outcomes were observed in this all-Black sample. Additional research is needed to replicate this observation. IMPLICATIONS: Despite known racial disparities and sex-based differences in NRT efficacy, little is known about sex differences in cessation among Black people who smoke. While we did not observe any differences by sex in smoking cessation outcomes within this all-Black sample, our results suggest that sex differences in the baseline level of cigarettes/day may play a critical role in cessation outcomes. Further research should replicate these observations and examine potential implications for cessation among Black people who smoke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.